BeiGene Announces Acceptance of a New Drug Application of Pamiparib in Ovarian Cancer in China
July 17, 2020 09:00 ET
|
BeiGene, LTD.
BEIJING, China and CAMBRIDGE, Mass., July 17, 2020 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing...